TY - JOUR
T1 - Cardiotrophin-1 is inversely associated with obesity in non-diabetic individuals
AU - Hung, Hao Chang
AU - Lu, Feng Hwa
AU - Wu, Hung Tsung
AU - Ou, Horng Yih
AU - Yang, Yi Ching
AU - Wu, Jin Shang
AU - Chang, Chih Jen
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Cardiotrophin-1 is known to be a key regulator of energy homeostasis, as well as glucose and lipid metabolism in vivo. However, there are inconsistent results of the association between cardiotrophin-1 and obesity in humans, possibly confounded by hyperglycemia. Therefore, the aim of this study was to investigate the relationships among cardiotrophin-1 levels, overweight and obese individuals without diabetes in a Chinese population. The median (inter-quarter range) serum cardiotrophin-1 levels were 447.9 (230.9, 913.9), 350.6 (201.1, 666.5), and 288.1 (162.3, 572.4) pg/ml in non-diabetic subjects who were of normal weight (n = 522), overweight (n = 203), and obese (n = 93), respectively (trend test p < 0.001). Subjects who were overweight and obese had significantly lower cardiotrophin-1 levels than those with normal weight. The multivariate linear regression analyses showed that overweight (beta =-338.718, 95% CI =-552.786 ∼-124.651, p < 0.01), obese (beta =-530.275, 95% CI =-832.967 ∼-227.583, p < 0.01), and smoking (beta =-377.375, 95% CI =-654.353 ∼-100.397, p < 0.01) were negatively related to cardiotrophin-1 after adjusting for age, gender, HOMA-IR, hypertension, total cholesterol, HDL, triglyceride, eGFR, ALT, and alcohol drinking. The results of this study provided epidemiological evidence that non-diabetic subjects who were overweight or obesity had significantly lower cardiotrophin-1 concentrations than those with normal weight, and both obesity and being overweight were inversely associated with cardiotrophin-1 levels.
AB - Cardiotrophin-1 is known to be a key regulator of energy homeostasis, as well as glucose and lipid metabolism in vivo. However, there are inconsistent results of the association between cardiotrophin-1 and obesity in humans, possibly confounded by hyperglycemia. Therefore, the aim of this study was to investigate the relationships among cardiotrophin-1 levels, overweight and obese individuals without diabetes in a Chinese population. The median (inter-quarter range) serum cardiotrophin-1 levels were 447.9 (230.9, 913.9), 350.6 (201.1, 666.5), and 288.1 (162.3, 572.4) pg/ml in non-diabetic subjects who were of normal weight (n = 522), overweight (n = 203), and obese (n = 93), respectively (trend test p < 0.001). Subjects who were overweight and obese had significantly lower cardiotrophin-1 levels than those with normal weight. The multivariate linear regression analyses showed that overweight (beta =-338.718, 95% CI =-552.786 ∼-124.651, p < 0.01), obese (beta =-530.275, 95% CI =-832.967 ∼-227.583, p < 0.01), and smoking (beta =-377.375, 95% CI =-654.353 ∼-100.397, p < 0.01) were negatively related to cardiotrophin-1 after adjusting for age, gender, HOMA-IR, hypertension, total cholesterol, HDL, triglyceride, eGFR, ALT, and alcohol drinking. The results of this study provided epidemiological evidence that non-diabetic subjects who were overweight or obesity had significantly lower cardiotrophin-1 concentrations than those with normal weight, and both obesity and being overweight were inversely associated with cardiotrophin-1 levels.
UR - http://www.scopus.com/inward/record.url?scp=84949187609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949187609&partnerID=8YFLogxK
U2 - 10.1038/srep17438
DO - 10.1038/srep17438
M3 - Article
C2 - 26621340
AN - SCOPUS:84949187609
SN - 2045-2322
VL - 5
JO - Scientific Reports
JF - Scientific Reports
M1 - 17438
ER -
